TROP-2 directed antibody-drug conjugates (ADCs): The revolution of smart drug delivery in advanced non-small cell lung cancer (NSCLC)
Claudia Parisi, Linda Mahjoubi, Anas Gazzah, Fabrice Barlési
Topics & Concepts
MedicineLung cancerOncologyNauseaInternal medicineCancerNeutropeniaAdverse effectChemotherapyHER2/EGFR in Cancer ResearchLung Cancer Treatments and MutationsMonoclonal and Polyclonal Antibodies Research